Cancer Nursing Today’s Post

The Y90 procedure, also known as radioembolization, involves delivering high doses of radiation directly to liver tumors through tiny beads loaded with the radioactive isotope yttrium-90. This targeted approach allows for the treatment of cancerous liver tumors while minimizing exposure to healthy tissue. It's a minimally invasive procedure, offering a treatment option that focuses on the affected area without significantly impacting the patient's overall health. Congratulations, Dr. Diamond, Andre, and the DI team! #diagnosticimaging #technologyinhealthcare

Radiotherapy, often associated primarily with advanced machinery like linear accelerators, is a complex, multidisciplinary medical field. It involves meticulous planning by a team of oncologists, medical physicists, and radiation therapists administrating treatment to individual cancer patients. #radiotherapyin #RTT #radiotherapy

🌸Breast Cancer Awareness Month 🌸 Whether or not a patient can access the care they need shouldn't be up for debate. We believe that your patients deserve uncomplicated access to MRI scans, especially because 98% of SCS patients are expected to need at least 1 MRI within 10 years of implant.(1) See risk information: https://bit.ly/4fhPDBJ Consider how your decisions today could impact optimal patient care down the road. Learn more about Inceptiv™ SCS system now providing 1.5T and 3T full-body MRI conditional access, go to Medtronic.com/Inceptiv. #MDTPainInterventions #MRI #MRIAccess #InceptivSCS #BreastCancerAwarenessMonth 1. Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531-E537 Product usage represented may not be approved or cleared in all markets.

Treating brain tumors is one of the most significant and complex challenges in medicine. Due to their sensitive location in the brain, these tumors require precise and specialized treatment methods. One of the challenges is determining the extent of tumor size changes after radiation therapy. In this short clip, we introduce 334 Aqua Med Soft's latest AI-based innovation.

Our innovative treatment method for tongue cancer utilizes radiation therapy in conjunction with a unique, internationally patented tongue-immobilizing spacer. This device employs suction to stabilize and secure the tongue in a fixed position, ensuring precise and targeted delivery of radiation. By minimizing tongue movement during treatment, we aim to enhance the effectiveness of radiation therapy while reducing potential side effects to surrounding healthy tissues. The sagittal plane MRI video clearly illustrates that the tongue remains entirely motionless, even when the patient swallows. This powerful evidence showcases the efficacy of our tongue-immobilizing device in ensuring consistent and precise tongue positioning during the course of radiation therapy. #TongueCancer #SBRT #MRI #Cooqoo #SpaceORAL

So is it just a chair? Absolutely not. We believe this is the future of radiotherapy, allowing for treatment in a more natural, upright position. This approach aims to provide greater comfort, enables direct patient-therapist communication, and streamlines the treatment process for better efficiency and effectiveness. Moreover, it has just received 510(k) regulatory clearance in the US, opening doors for potential advancements in cancer treatments such as FLASH RT, BNCT, Carbon Ion Therapy, and Ultra-Compact Proton therapy. This 'chair' represents a more human way of treating with radiation therapy. 🌟 #Radiotherapy #Uprightradiotherapy #Innovation #Healthcare #Patientcare #Medicaltechnology

Patients often ask us to compare photon therapy to proton therapy. Here is our newest blog that covers this topic: https://lnkd.in/gXgd_eVg If you'd like more information, please visit us at TexasRadiotherapy.com Dr. Matthew Cavey #FortWorth #RadiationOncology

This week, I explored the fascinating world of Targeted Alpha Therapy (TAT), an innovative form of radiotherapy that holds potential in cancer treatment. The scientific principles and investment trends are detailed in my latest article, "The Science Behind TAT: Precision, Power, and Promise."

Local recurrence in malignant peripheral nerve sheath tumours: multicentre cohort study ➡️https://lnkd.in/dAB3YF2H This study analyses treatment and risk factors for first and second local recurrences (LR1 and LR2) in malignant peripheral nerve sheath tumours (MPNSTs) using a large, multicentre cohort from 1988 to 2019. Findings indicate that high-grade tumours, positive margins and large tumour size increase LR1 risk, mitigated by perioperative radiotherapy. Surgically treated LR1 cases are associated with better overall survival, underscoring the need for tailored management in large, high-grade MPNSTs with R1 resections. 👏👏👏Christianne Jansma, Ibtissam Acem, Dirk Grünhagen, Cornelis Verhoef, Enrico & the MONACO Collaborators

Spectral CT & CAS One & ECT in combination rocks! Dear IR & IntOnc community, I would like to share an interesting case from this week with you. We successfully treated a patient with an extensive retroperitoneal tumour recurrence after tumor nephrectomy (RCC) with the combined image guidance Spectral CT and CAS One and ECT. The images are busy, therefore the system from left to right: better delineation of the vital tumour margin in the spectral reconstruction 55 mono keV compared to standard CT. Clear planning of the subdomains and access trajectories with CAS One IR. The parallelism of the electrodes is well documented in the subsequent ECT. Two days later, we see the desired necrosis in the entire treatment area. Spectral CT & CAS One IR & ECT is not just the ‘new kid on the block’ - it's a gamechanger! WEGE KLINIK Philips CASCINATION IGEA S.p.A.